In a report released today, Andrew Stott from UBS maintained a Buy rating on LANXESS (LNXSF – Research Report), with a price target of EUR68.00. The company’s shares closed last Thursday at $43.50, close to its 52-week low of $38.00.
According to TipRanks.com, Stott is a 4-star analyst with an average return of 9.2% and a 61.0% success rate. Stott covers the Basic Materials sector, focusing on stocks such as Wacker Chemie AG, Clariant AG, and Nutrien.
LANXESS has an analyst consensus of Strong Buy, with a price target consensus of $79.25, a 79.1% upside from current levels. In a report issued on February 24, Baader Bank also maintained a Buy rating on the stock with a EUR79.00 price target.
The company has a one-year high of $77.88 and a one-year low of $38.00. Currently, LANXESS has an average volume of 918.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
LANXESS AG is a holding company, which engages in the provision of specialty chemicals. It operates through the following segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, High Performance Materials, and Arlanxeo. The Advanced Intermediates segment consists of industrial chemical intermediates and a key player in the custom synthesis, and manufacturing of chemical precursors and specialty active ingredients. The Specialty Additives segment focuses on specialty additive chemicals. The Performance Chemicals segment covers application-oriented process, and functional chemicals operations. The High Performance Materials segment represents plastic activities in the engineering materials. The Arlanxeo segment refers to synthetic rubber activities. The company was founded on July 1, 2004 and is headquartered in Leverkusen, Germany.
Read More on LNXSF: